Product Introduction
Bioactivity


英文名: KY-226

描述: KY-226 是选择性的，口服活性的和变构蛋白酪氨酸磷酸酶 1B 抑制剂，IC50=0.25 μM，且不激活 PPARγ 。它可以保护神经元免受脑缺血损伤。它通过增强胰岛素和瘦素信号传导发挥抗糖尿病和抗肥胖作用。

体内活性: In db/db mice, the oral administration of KY-226 (10 and 30 mg/kg/day, 4 weeks) significantly reduced plasma glucose and triglyceride levels as well as hemoglobin A1c values without increasing body weight gain, while pioglitazone exerted similar effects with increases in body weight gain.?KY-226 attenuated plasma glucose elevations in the oral glucose tolerance test.?KY-226 also increased pIR and phosphorylated Akt in the liver and femoral muscle.?In high-fat diet-induced obese mice, the oral administration of KY-226 (30 and 60 mg/kg/day, 4 weeks) decreased body weight gain, food consumption, and fat volume gain with increases in phosphorylated STAT3 in the hypothalamus.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 25 mg/mL (51.9 mM)


关键字: inhibit | anti-diabetic | leptin | ZO-1 | LPS | insulin | KY 226 | KY226 | phosphorylated | Akt | anti-obesity | PTP1B | Phosphatase | KY-226 | neurons | Inhibitor

相关产品: Ginkgolic acid C17:1 | BN82002 | AS1949490 | Razuprotafib | PROTAC PTPN2 degrader-2 TFA | NSC-87877 disodium | TD52 | Mulberrofuran G | Itacitinib adipate | BCI-215

相关库: Anti-Neurodegenerative Disease Compound Library | Glycometabolism Compound Library | Bioactive Compounds Library Max | Phosphatase Inhibitor Library | Inhibitor Library | Metabolism Compound Library | Endocrinology-Hormone Compound Library | Orally Active Compound Library | NO PAINS Compound Library | Bioactive Compound Library